HBB rs886043561: Understanding This Pathogenic Variant
The rs886043561 variant is a rare, pathogenic genetic mutation within the HBB gene. It is clinically associated with hemoglobinopathies, a group of inherited disorders affecting hemoglobin function.
What each genotype means
Typical hemoglobin beta
This genotype represents the common, non-pathogenic sequence for this specific location in the HBB gene. It is not associated with the hemoglobinopathies or clinical conditions linked to the pathogenic variant at this site.
This is the most common genotype found in the general population.
HBB variant carrier
Carrying one copy of this variant means you possess a genetic change in the HBB gene that is associated with hemoglobinopathies. You should discuss the clinical implications of this result with a genetic counselor or your healthcare provider to understand your specific health profile.
This genotype is rare in the general population.
HBB variant homozygous
This genotype indicates that both copies of the HBB gene carry this pathogenic variant. This is associated with an increased risk for hemoglobinopathies, and you should consult with a medical specialist or hematologist to discuss your health status and any necessary clinical management.
This genotype is extremely rare in the general population.
What is the rs886043561 Variant?
The rs886043561 variant represents a specific change in the DNA sequence of the HBB gene, located on chromosome 11. In genetics, a variant or single nucleotide polymorphism (SNP) signifies a variation at a single DNA position. This particular variant is classified as pathogenic, meaning it is recognized by clinical geneticists as an alteration that can impair the normal function of the gene product. The HBB gene is crucial as it provides the blueprint for the beta-globin protein, a key component of hemoglobin. Consequently, alterations in its sequence can significantly impact the body's ability to transport oxygen effectively via red blood cells.
The Role of the HBB Gene
The HBB gene is essential for producing the beta-globin protein, which, along with alpha-globin, forms hemoglobin. Hemoglobin is the protein within red blood cells responsible for carrying oxygen from the lungs to tissues throughout the body. In healthy adults, functional hemoglobin requires two alpha-globin and two beta-globin subunits. Disruptions in the HBB gene can lead to the production of abnormal beta-globin or insufficient amounts of it, resulting in altered hemoglobin structure or quantity. These alterations are the root cause of various hemoglobinopathies, such as sickle cell disease and thalassemia, which can manifest with symptoms ranging from anemia to severe organ damage.
Research and Clinical Significance
Research on HBB variants like rs886043561 is primarily driven by the study of hemoglobinopathies. While common variants are well-documented, rarer pathogenic variants are often identified through clinical genetic testing for individuals with unexplained blood disorders. Databases like ClinVar and GenCC aggregate data from clinical laboratories and research to assess the pathogenicity of variants. For rs886043561, evidence indicates it is a pathogenic mutation. However, the clinical presentation of HBB variants can be complex, influenced by other genetic factors, co-inherited conditions, and environmental influences, underscoring the need for comprehensive clinical evaluation.
Population Frequency
The rs886043561 variant is considered rare in the general population. Variants associated with hemoglobinopathies are sometimes more prevalent in populations with historical exposure to malaria, such as those with ancestry from Africa, the Mediterranean, the Middle East, or South Asia. However, as rs886043561 is specifically identified as a rare variant, its frequency is much lower than that of more common HBB mutations. Population databases like gnomAD help track variant frequencies, but data for very rare variants can be limited, potentially leading to variations in observed prevalence across different ethnic or geographic groups.
Your Genetic Information: What You Can Do
Information about a genetic variant like rs886043561 should be viewed as educational and not a medical diagnosis. Genetic findings are one aspect of overall health. If you have concerns about your genetic results or a family history of blood disorders, it is crucial to consult with a healthcare provider or a certified genetic counselor. They can interpret these findings within the context of your personal health history, symptoms, and family background. If this variant is associated with medication response, do not alter your treatment or dosage without discussing it directly with your clinician or pharmacist.
How common is this variant?
The rs886043561 variant is classified as rare in the general population. Population databases indicate limited presence across various ancestries, with potential variations in observed frequency between different ethnic or geographic groups.
Frequently asked questions
What does it mean if I am a carrier for an HBB variant?
Being a carrier (having one copy of the variant) typically means you do not have the associated disease yourself but could pass the variant to your children. It's advisable to consult a genetic counselor for family planning and to discuss potential testing for relatives.
Does having the rs886043561 variant mean I have sickle cell disease?
Not necessarily. A diagnosis of sickle cell disease usually involves specific combinations of HBB variants. While rs886043561 is associated with hemoglobinopathies, a definitive diagnosis requires a comprehensive genetic profile and clinical evaluation by a doctor.
Why is this variant labeled as 'higher-attention'?
The 'higher-attention' label signifies that the variant has potential clinical relevance concerning disease risk, distinguishing it from common, neutral genetic variations. It does not substitute for a medical assessment of your health status.
Can I rely on direct-to-consumer DNA tests for this variant?
The accuracy and scope of variants tested can differ among commercial DNA kits. For clinical concerns, confirmation through diagnostic testing ordered by a healthcare provider is the standard medical practice.
Sources & further reading
Educational information only, last refreshed 10/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs886043561?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HBB
This variant is a known pathogenic mutation in the HBB gene linked to beta-thalassemia.
This variant is associated with hemoglobin-related traits and is frequently referenced in clinical databases.
This variant causes the substitution of valine for glutamic acid in the beta-globin chain, leading to sickle cell trait or disease depending on zygosity.
Pathogenic nonsense mutation (c.118C>T / p.Gln40Ter / codon 39 nonsense) causing beta-zero thalassemia and classic carrier status (beta-thalassemia minor).
Causes Hemoglobin S-Antilles, an ancestral structural beta-globin mutation conferring altered oxygen affinity and sickle cell pathology under low oxygen tension.
This variant, known as Hb C-Harlem, involves a double mutation in the HBB gene that can lead to sickle-beta-thalassemia-like phenotypes.